The standardized extract of Ginkgo biloba (EGb 761) has been widely employe
d for its significant benefit in neurodegenerative disorders. Although anti
oxidative actions have been attributed to this extract, the mechanisms of t
he multiple principles involved in this pharmacological activity are not co
mpletely established. Parkinson's and Alzheimer's diseases are frequently a
ssociated with oxidative stress and defects in the cellular protective mech
anisms. In this study, the lipid peroxidation (LPO) and the activity of the
antioxidant enzymes, catalase (CAT) and superoxide dismutase (SOD) were ev
aluated in the hippocampus, striatum and substantia nigra (SN) of rats trea
ted with EGb 761. An increase in the CAT and SOD activities in the hippocam
pus, striatum and SN, and a decrease of the LPO in the hippocampus were obs
erved. These data are additional to the antioxidant properties of EGb 761 r
eported in the literature and indicate a possible role for the extract in t
he treatment of diseases involving free radicals and oxidative damage. Copy
right (C) 2001 John Wiley & Sons, Ltd.